Full text
| |
| Author(s): |
Paulo Vitor Soeiro Pereira
Total Authors: 1
|
| Document type: | Master's Dissertation |
| Press: | São Paulo. |
| Institution: | Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB/SDI) |
| Defense date: | 2008-09-25 |
| Examining board members: |
Antonio Condino Neto;
Beatriz Tavares Costa Carvalho;
Marcelo de Franco
|
| Advisor: | Antonio Condino Neto |
| Abstract | |
Phagocyte activation is critical role for host defense against several pathogens, so that studies developing alternatives for activating these cell are very important. We investigated the effects of BAY 41-2272 on phagocytes activation. For this purpose we evaluated several aspects indicating cellular activation, as phagocytosis, superoxide release and microbicidal activity. We used PBMC, neutrophils and THP-1 cell lineage cultured or not with BAY 41-2272 (1mM and 3mM) for 1h or 48h at 37°C. Superoxide release was tested by superoxide dismutase-inhibitable cytochrome c reduction assay; phagocytosis was evaluated through co-culture with zymosan particles and counting of ingested particles; and microbicidal activity was measured through co-incubation with enteropathogenic E. coli followed by counting of CFU from recovered bacteria from phagocytes. We analyzed the IL-12, IFN-g and TNF-a cytokine production and gp91phox gene expression. All cell types showed a response to treatments. PBMC, PMN and THP-1 treated with BAY 41-2272 produced significantly more superoxide (about 50% more), and presented significantly more phagocytic (about 54% more), microbicidal (about twice) activity than control group and production more TNF-a than control group. The expression of CYBB gene was more expressed on treated cells than control. BAY 41-2272, especially at 3mM, showed a great potential in activation of phagocytes in several aspects. This potential should be investigated at the light of new therapies seeking infection control, mainly in immunodeficiency. (AU) | |